ALLISON JO MARTIN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner NEWBURGH, IN NPI 1003527722
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner IN NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$1,937.83
- Category: General Payments
- Program years: PY2023–2024
- Record count: 90
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,268.39 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,169.39 | 57 |
| Education | $99.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $203.32 | 10 |
| ABBVIE INC. | $136.96 | 9 |
| Merck Sharp & Dohme Corporation | $135.96 | 7 |
| SANOFI-AVENTIS U.S. LLC | $99.00 | 1 |
| GENZYME CORPORATION | $84.43 | 2 |
| Janssen Biotech, Inc. | $71.08 | 3 |
| Incyte Corporation | $54.35 | 2 |
| PFIZER INC. | $53.00 | 3 |
| Acerta Pharma LLC | $45.74 | 2 |
| PharmaEssentia USA Corporation | $43.68 | 2 |
| Adaptive Biotechnologies Corporation | $43.25 | 2 |
| Regeneron Healthcare Solutions, Inc. | $40.79 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $35.90 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.66 | 1 |
| Genmab U.S., Inc. | $31.17 | 2 |
| Daiichi Sankyo Inc. | $26.44 | 1 |
| Celgene Corporation | $23.91 | 1 |
| Stemline Therapeutics Inc. | $21.88 | 1 |
| EISAI INC. | $21.14 | 1 |
| Blueprint Medicines Corporation | $17.90 | 1 |
| Astellas Pharma US Inc | $15.29 | 1 |
| Genentech USA, Inc. | $15.07 | 1 |
| Tempus AI, Inc | $14.47 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.